超声乳化透明晶状体吸除术治疗高度近视临床观察

目的:探讨超声乳化透明晶状体吸除联合人工晶状体植入术治疗高度近视的有效性和安全性。方法:对2013年1-7月在本院选取的29例(43只眼)高度近视患者行超声乳化透明晶状体吸除联合人工晶状体植入术,观察其临床效果。所有患者平均(51.93±6.89)岁,术前矫正视力(0.46±0.18)D,平均近视度数(-10.94±6.14)D,平均角膜散光度数(-1.04±0.67)D,平均眼轴长度(27.73±2.12)mm。结果:术后所有患者裸眼视力均提高,术后矫正视力(0.69±0.17)D,与术前比较差异有统计学意义(t=5.9987,P0.001),术后平均近视度数(-1.73±0.77)D,与术前预留屈光度基本吻合;术后平均角膜散光度数(-1.23±0.66)D,与术前比较差异无统计学意义(t=1.2963,P0.05)。术后随访3个月,未发生晶状体后囊膜混浊,未见视网膜裂孔、视网膜脱离及黄斑囊样水肿。结论:超声乳化透明晶状体吸除联合人工晶状体植入术是矫治高度近视安全、有效的方法,具有术后视力好、并发症少、预测屈光状态准确性及稳定性好等优点。

Clinical Observation of Transparent Lens Phacoemulsification in the Treatment of High Myopia

Objective：To investigate the transparent lens phacoemulsification efficacy and safety of combined with intraocular lens implantation for high myopia.Method：29 patients（43 eyes）with high myopia were selected in our hospital from January 2013 to July 2013,they were treated with transparent lens phacoemulsification combined with intraocular lens implantation.The average age of all the patients was（51.93±6.89） years old,preoperative corrected vision was（0.46±0.18）D,the average degree of myopia was（-10.94±6.14）D,the mean corneal astigmatism was（-1.04±0.67）D,the mean axial length was（27.73±2.12）mm.Result：All patients visual acuity improved after operation;postoperative visual acuity was（0.69±0.17）D,compared with the preoperative,the difference was statistically significant（t=5.9987,P0.05）.Patients were followed up for 3 months,without the occurrence of posterior capsular opacification,no retinal hole,retinal detachment and macular cystoid edema.Conclusion：Transparent lens phacoemulsification combined with intraocular lens implantation is safe and effective for high myopia,with good visual acuity,fewer complications,prediction accuracy and stability of the refractive state.